The serotonin reuptake inhibitor citalopram does not affect colonic sensitivity or compliance in rats

European Journal of Pharmacology

Volumn 570, Issue 1-3, 2007, Pages 203-211

  Käll, Erika ^a   Lindström, Erik ^a   Martinez, Vicente ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Citalopram; Colon compliance; Irritable bowel syndrome; Lidocaine; Serotonin; SSRI; Visceral sensitivity

Indexed keywords

CITALOPRAM;

ANIMAL EXPERIMENT; ARTICLE; COLON; COLON DILATATION; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; IRRITABLE COLON; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; VISCERAL PAIN;

ANESTHETICS, LOCAL; ANIMALS; CITALOPRAM; COLON; COLONIC DISEASES, FUNCTIONAL; COMPLIANCE; FEMALE; LIDOCAINE; MODELS, BIOLOGICAL; PELVIC PAIN; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 34547866105     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.032     Document Type: Article

References (49)

1. Arvidsson S., Brusberg M., Larsson M., Larsson H., Lindström E., and Martinez V. CB1 receptors mediate the analgesic effects of cannabinoids on visceral pain in rodents. Neurogastroenterol. Motil. 17 Sppl 2 (2005) 20 (Abstract)
2. Arvidsson S., Larsson M., Larsson H., Lindstrom E., and Martinez V. Assessment of visceral pain-related pseudo-affective responses to colorectal distension in mice by intracolonic manometric recordings. J. Pain 7 (2006) 108-118
3. Banner S.E., Carter M., and Sanger G.J. 5-Hydroxytryptamine3 receptor antagonism modulates a noxious visceral pseudoaffective reflex. Neuropharmacology 34 (1995) 263-267
4. Bharucha A.E., Camilleri M., Zinsmeister A.R., and Hanson R.B. Adrenergic modulation of human colonic motor and sensory function. Am. J. Physiol. 273 (1997) G997-G1006
5. Blardi P., de Lalla A., Urso R., Auteri A., Dell'Erba A., Bossini L., and Castrogiovanni P. Activity of citalopram on adenosine and serotonin circulating levels in depressed patients. J. Clin. Psychopharmacol. 25 (2005) 262-266
6. Bomholt S.F., Mikkelsen J.D., and Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48 (2005) 252-563
7. Bouali S., Evrard A., Chastanet M., Lesch K.P., Hamon M., and Adrien J. Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur. J. Neurosci. 18 (2003) 2203-2212
8. Bundgaard C., Larsen F., Jorgensen M., and Gabrielsson J. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels. Eur. J. Pharm. Sci. 29 (2006) 394-404
9. Camilleri M., Atanasova E., Carlson P.J., Ahmad U., Kim H.J., Viramontes B.E., McKinzie S., and Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123 (2002) 425-432
10. Ceglia I., Acconcia S., Fracasso C., Colovic M., Caccia S., and Invernizzi R.W. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors. Br. J. Pharmacol. 142 (2004) 469-478
11. Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J., Blaszyk H., Crowell M.D., Sharkey K.A., Gershon M.D., Mawe G.M., and Moses P.L. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126 (2004) 1657-1664
12. Coates M.D., Johnson A.C., Greenwood-Van Meerveld B., and Mawe G.M. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol. Motil. 18 (2006) 464-471
13. Dunlop S.P., Jenkins D., Neal K.R., and Spiller R.C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125 (2003) 1651-1659
14. Gershon M.D. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment. Pharmacol. Ther. 13 Suppl 2 (1999) 15-30
15. Gershon M.D. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 20 Suppl 7 (2004) 3-14
16. Holdcroft A., Sapsed-Byrne S., Ma D., Hammal D., and Forsling M.L. Sex and oestrous cycle differences in visceromotor responses and vasopressin release in response to colonic distension in male and female rats anaesthetized with halothane. Br. J. Anaesth. 85 (2000) 907-910
17. Invernizzi R., Bramante M., and Samanin R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain. Res. 696 (1995) 62-66
18. Jarosik J., Legutko B., Unsicker K., and von Bohlen Und Halbach O. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Exp. Neurol. 204 (2007) 20-28
19. Kilkens T.O., Honig A., Fekkes D., and Brummer R.J. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Aliment. Pharmacol. Ther. 22 (2005) 865-874
20. Korzeniewska-Rybicka I., and Plaznik A. Analgesic effect of antidepressant drugs. Pharmacol. Biochem. Behav. 59 (1998) 331-338
21. Kuiken S.D., Tytgat G.N., and Boeckxstaens G.E. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin. Gastroenterol. Hepatol. 1 (2003) 219-228
22. Ladabaum U., and Glidden D. Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans. Neurogastroenterol. Motil. 14 (2002) 395-402
23. Leo R.J., and Brooks V.L. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Curr. Opin. Investig. Drugs 7 (2006) 637-642
24. Leventhal L., Smith V.A., Hornby G., Andree T.H., Brandt M.R., and Rogers K.E. Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain. J. Pharmacol. Exp. Ther. 320 (2007) 1178-1185
25. Linden D.R., Chen J.X., Gershon M.D., Sharkey K.A., and Mawe G.M. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am. J. Physiol. 285 (2003) G207-G216
26. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., and Spiller R.C. Functional bowel disorders. Gastroenterology 130 (2006) 1480-1491 (Erratum in: 2006, Gastroenterology 131:688)
27. Malcolm A., Camilleri M., Kost L., Burton D.D., Fett S.L., and Zinsmeister A.R. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment. Pharmacol. Ther. 14 (2000) 783-793
28. Martinez V., Thakur S., Mogil J.S., Taché Y., and Mayer E.A. Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain 81 (1999) 179-186
29. Mayer E.A., Berman S., Chang L., and Naliboff B.D. Sex-based differences in gastrointestinal pain. Eur. J. Pain 8 (2004) 451-463
30. Million M., Maillot C., Adelson D.A., Nozu T., Gauthier A., Rivier J., Chrousos G.P., Bayati A., Mattsson H., and Taché Y. Peripheral injection of sauvagine prevents repeated colorectal distension-induced visceral pain in female rats. Peptides 26 (2005) 1188-1195
31. Miwa J., Echizen H., Matsueda K., and Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion 63 (2001) 188-194
32. Ning Y., Zhu J.X., and Chan H.C. Regulation of ion transport by 5-hydroxytryptamine in rat colon. Clin. Exp. Pharmacol. Physiol. 31 (2004) 424-428
33. Olden K.W. The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs. CNS Spectr. 10 (2005) 891-896
34. Sapsed-Byrne S., Ma D., Ridout D., and Holdcroft A. Estrous cycle phase variations in visceromotor and cardiovascular responses to colonic distension in the anesthetized rat. Brain Res. 742 (1996) 10-16
35. Schoenfeld P. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work. Gastroenterol. Clin. North Am. 34 (2005) 319-335
36. Shin S.W., Eisenach J.C., Rao S.G., and Tong C. The monoamine reuptake inhibitor milnacipran does not affect nociception to acute visceral distension in rats. Anesth. Analg. 98 (2004) 1365-1369
37. Singh V.P., Jain N.K., and Kulkarni S.K. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res. 915 (2001) 218-226
38. Singh V.P., Patil C.S., Jain N.K., Singh A., and Kulkarni S.K. Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice. Pharmacology 69 (2003) 115-122
39. Sivarao D.V., Newberry K., and Lodge N.J. Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat. Eur. J. Pharmacol. 494 (2004) 23-29
40. Spiegel K., Kalb R., and Pasternak G.W. Analgesic activity of tricyclic antidepressants. Ann. Neurol. 13 (1983) 462-465
41. Tack J., Broekaert D., Corsetti M., Fischler B., and Janssens J. Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man. Aliment. Pharmacol. Ther. 23 (2006) 265-274
42. Tack J., Broekaert D., Fischler B., Oudenhove L.V., Gevers A.M., and Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 55 (2006) 1095-1103
43. Tack J., Fried M., Houghton L.A., Spicak J., and Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Aliment. Pharmacol. Ther. 24 (2006) 183-205
44. Tammpere A., Brusberg M., Axenborg J., Hirsch I., Larsson H., and Lindstrom E. Evaluation of pseudo-affective responses to noxious colorectal distension in rats by manometric recordings. Pain 116 (2005) 220-226
45. Thompson W.G., Longstreth G.F., Drossman D.A., Heaton K.W., Irvine E.J., and Muller-Lissner S.A. Functional bowel disorders and functional abdominal pain. Gut 45 Suppl 2 (1999) II43-II47
46. Verne G.N., Sen A., and Price D.D. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J. Pain 6 (2005) 493-496
47. Viramontes B.E., Malcolm A., Camilleri M., Szarka L.A., McKinzie S., Burton D.D., and Zinsmeister A.R. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am. J. Physiol. 281 (2001) G1468-G1476
48. Wang L., Martinez V., Kimura H., and Taché Y. 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice. Am. J. Physiol. 292 (2007) G419-G428
49. Whitehead K.J., Pearce S.N., and Bowery N.G. Characterisation of 5-HT efflux from the rat spinal cord dorsal horn in vivo. Br. J. Pharmacol. 129 (2000) 62P